The Natl. Council on Patient Information & Education (NCPIE) will hold its annual meeting Oct. 3-4 in D.C. For information or registration material write: NCPIE Third Annual Meeting; c/o Greg Thomas, Conference Manager; Office of CME; George Washington University Medical Center; 2300 K Street, NW; Washington, D.C. 20037; 202-676-4285
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”